Stryker Stock Fundamentals
| SYK Stock | USD 335.61 1.54 0.46% |
Stryker fundamentals help investors to digest information that contributes to Stryker's financial success or failures. It also enables traders to predict the movement of Stryker Stock. The fundamental analysis module provides a way to measure Stryker's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Stryker stock.
At this time, Stryker's Operating Income is quite stable compared to the past year. EBIT is expected to rise to about 4.1 B this year, although the value of Non Operating Income Net Other will most likely fall to (149.3 M). Stryker | Select Account or Indicator |
Stryker Company Return On Equity Analysis
Stryker's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Stryker Return On Equity | 0.18 |
Most of Stryker's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Stryker is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Stryker Return On Equity Historical Pattern
Today, most investors in Stryker Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Stryker's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's return on equity growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Stryker return on equity as a starting point in their analysis.
Stryker Return On Equity |
| Timeline |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Stryker Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Stryker has a Return On Equity of 0.1798. This is 100.75% lower than that of the Health Care Equipment & Supplies sector and 102.06% lower than that of the Health Care industry. The return on equity for all United States stocks is 158.0% lower than that of the firm.
Stryker Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Stryker's current stock value. Our valuation model uses many indicators to compare Stryker value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Stryker competition to find correlations between indicators driving Stryker's intrinsic value. More Info.Stryker is rated third in return on equity category among related companies. It is rated second in return on asset category among related companies reporting about 0.38 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Stryker is roughly 2.62 . At this time, Stryker's Return On Equity is quite stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Stryker by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Stryker's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Stryker's earnings, one of the primary drivers of an investment's value.Stryker Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Stryker's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Stryker could also be used in its relative valuation, which is a method of valuing Stryker by comparing valuation metrics of similar companies.Stryker is currently under evaluation in return on equity category among related companies.
Stryker ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Stryker's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Stryker's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Stryker Fundamentals
| Return On Equity | 0.18 | ||||
| Return On Asset | 0.0687 | ||||
| Profit Margin | 0.15 % | ||||
| Operating Margin | 0.24 % | ||||
| Current Valuation | 138.53 B | ||||
| Shares Outstanding | 380.47 M | ||||
| Shares Owned By Insiders | 5.39 % | ||||
| Shares Owned By Institutions | 78.85 % | ||||
| Number Of Shares Shorted | 4.32 M | ||||
| Price To Earning | 63.07 X | ||||
| Price To Book | 7.00 X | ||||
| Price To Sales | 6.35 X | ||||
| Revenue | 20.5 B | ||||
| Gross Profit | 11.65 B | ||||
| EBITDA | 4.95 B | ||||
| Net Income | 3.17 B | ||||
| Cash And Equivalents | 1.84 B | ||||
| Cash Per Share | 2.98 X | ||||
| Total Debt | 12.99 B | ||||
| Debt To Equity | 0.88 % | ||||
| Current Ratio | 2.00 X | ||||
| Book Value Per Share | 48.92 X | ||||
| Cash Flow From Operations | 3.71 B | ||||
| Short Ratio | 4.22 X | ||||
| Earnings Per Share | 8.25 X | ||||
| Price To Earnings To Growth | 2.92 X | ||||
| Target Price | 372.04 | ||||
| Number Of Employees | 52 K | ||||
| Beta | 0.91 | ||||
| Market Capitalization | 128.16 B | ||||
| Total Asset | 39.91 B | ||||
| Retained Earnings | 16.77 B | ||||
| Working Capital | 4.6 B | ||||
| Current Asset | 1.15 B | ||||
| Current Liabilities | 707.5 M | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 1.07 % | ||||
| Net Asset | 39.91 B | ||||
| Last Dividend Paid | 3.05 |
About Stryker Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Stryker's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Stryker using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Stryker based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 351.9 M | 198.2 M | |
| Total Revenue | 20.5 B | 21.5 B | |
| Cost Of Revenue | 7.4 B | 7.8 B | |
| Stock Based Compensation To Revenue | 0.01 | 0.01 | |
| Sales General And Administrative To Revenue | 0.34 | 0.30 | |
| Research And Ddevelopement To Revenue | 0.07 | 0.05 | |
| Capex To Revenue | (0.03) | (0.03) | |
| Revenue Per Share | 54.00 | 56.70 | |
| Ebit Per Revenue | 0.19 | 0.14 |
Currently Active Assets on Macroaxis
When determining whether Stryker is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stryker Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:Check out Stryker Piotroski F Score and Stryker Altman Z Score analysis. For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Stryker Stock analysis
When running Stryker's price analysis, check to measure Stryker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stryker is operating at the current time. Most of Stryker's value examination focuses on studying past and present price action to predict the probability of Stryker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stryker's price. Additionally, you may evaluate how the addition of Stryker to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
Is Stryker's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.027 | Dividend Share 3.05 | Earnings Share 8.25 | Revenue Per Share 53.999 | Quarterly Revenue Growth 0.118 |
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.